Talc Powder Lawsuit Update October 2026: 69,340 Cases Pending, the $5.5B Proposal, and Who Can Still File
As of October 2026, the talc powder lawsuits stand at 69,340 pending cases in federal multidistrict litigation (MDL 2738), with Johnson & Johnson's proposed $5.5 billion ovarian-cancer resolution still conditional on 95% claimant participation — and no final global settlement. Mesothelioma cases continue in state courts, where juries awarded significant 2026 verdicts.
Key facts:
- 69,340 actions pending in MDL 2738 (D.N.J., Judge Shipp) as of October 1, 2026 — ovarian and gynecologic-cancer claims; mesothelioma cases proceed in state courts.
- A PROPOSED $5.5 billion resolution for ovarian-cancer claims only (~76,000 claims) was announced July 27, 2026, conditional on 95% claimant participation — it is not a final settlement.
- J&J's third bankruptcy attempt (Red River Talc LLC) was rejected on March 31, 2025, and the company said it would return to the tort system.
- Real 2026 jury verdicts include $32 million (Los Angeles, mesothelioma) and $10 million (New Orleans, mesothelioma), plus late-2025 awards up to $1.56 billion in Baltimore.
- In July 2024, the WHO's IARC classified talc as Group 2A, "probably carcinogenic" to humans, on limited evidence for ovarian cancer.
For a video explainer of mass-tort court proceedings, see the Problem Solved YouTube channel.
69,340 cases and counting: the current status
An MDL is a federal procedure that groups similar lawsuits before one judge for pre-trial proceedings. The talc litigation is MDL 2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, in the U.S. District Court for the District of New Jersey, before Judge Michael A. Shipp.
As of October 1, 2026, 69,340 actions were pending in the MDL, per the Judicial Panel on Multidistrict Litigation's October 2026 report. Nuance: the MDL covers ovarian and gynecologic-cancer claims; talc mesothelioma cases proceed individually in state courts.
The proposed $5.5 billion resolution — what is actually on the table
On July 27, 2026, Johnson & Johnson announced a PROPOSED resolution of ovarian-cancer claims only. Key terms, as announced:
The headline figure: $5.5 billion for approximately 76,000 ovarian-cancer claims, with the first payment — up to $3 billion — targeted for 2027, and further payments in 2028.
The catch: the proposal is CONDITIONAL on 95% claimant participation. Below that threshold, there is no deal. It also EXCLUDES mesothelioma claims and future (unfiled) claims. As of October 2026, there is NO final global settlement — this is a proposal, not a completed deal.
Why J&J's third bankruptcy attempt failed
J&J's third bankruptcy attempt — through a subsidiary called Red River Talc LLC — was rejected on March 31, 2025, by Judge Christopher Lopez of the Southern District of Texas.
The court cited flawed claimant voting and non-debtor releases barred by the Supreme Court's decision in Harrington v. Purdue Pharma. J&J did not appeal, said it would "return to the tort system to litigate and defeat these meritless talc claims," and reversed roughly $7 billion it had set aside for a bankruptcy resolution.
Real verdicts: what juries decided in 2025–2026
Juries have returned awards in individual talc trials — each tied to a specific plaintiff, not a general payout benchmark:
- $32 million — Los Angeles Superior Court, June 2026, for Maria Lozano, a mesothelioma claim.
- $10 million — New Orleans, August 2026, for Lynne Roy, a mesothelioma claim; the jury apportioned J&J's share at roughly $1.2 million.
- $1.56 billion — Baltimore, December 2025, for Cherie Craft, peritoneal mesothelioma — the largest individual talc award on record, likely to be reduced on appeal.
- $966 million — Los Angeles, December 2025, for Mae Moore — $16 million compensatory survived after punitive damages were struck in March 2026.
- $65.5 million — Minnesota, December 2025, for Anna Jean Carley.
- $40 million — Los Angeles, December 2025, for two ovarian-cancer plaintiffs.
Who can still file
Plaintiffs allege that J&J cosmetic talc products — Johnson's Baby Powder and Shower to Shower — contained asbestos contamination, and that long-term perineal use is associated with ovarian cancer; asbestos causes mesothelioma. J&J denies the claims. In July 2024, the WHO's International Agency for Research on Cancer classified talc as Group 2A, "probably carcinogenic to humans," on limited human evidence for ovarian cancer; asbestos-containing talc remains Group 1, carcinogenic.
Who may qualify: women diagnosed with ovarian cancer after long-term use of the named talc products, and individuals diagnosed with mesothelioma after cosmetic talc exposure. For help evaluating your situation, see our talc lawyer guide for 2026.
Statute of limitations means the legal deadline for filing a claim. For talc claims there is NO single national deadline: it varies by state, typically 1–3 years from diagnosis or discovery of the injury. Miss your state's deadline and the case is barred — so speak to a licensed attorney in your state promptly.
What hiring a lawyer costs (and what it doesn't)
A contingency fee means the lawyer is paid only if you recover money — there is nothing to pay upfront, and no fee is owed if there is no recovery. Talc firms typically charge 33–40% of the recovery: 33% for a pre-trial settlement, up to 40% if the case goes to trial, plus reimbursement of case costs (filing fees, experts, medical records).
For example, if a case settles for $300,000 with a 33% fee, the fee is $99,000, leaving $201,000 before case costs are deducted.
What compensation might you receive? Compensation varies widely by case. No reliable public per-case figures exist because most settlements are confidential. Your compensation depends on your specific facts: your diagnosis, your exposure history, the jurisdiction, and the defendant's conduct. Anyone quoting you a fixed settlement range for "talc cases" as a general rule is not telling you the truth.
Our guide to when to hire a talc lawyer covers timing, costs, and what to expect. For a parallel product-liability mass tort, see the AFFF firefighting foam lawsuit.
Who Benefits From This — and Who Does Not
As of October 2026, 69,340 cases are pending in the talc MDL 2738, and Johnson & Johnson’s proposed $5.5 billion resolution for ovarian cancer only remains conditional on 95% claimant participation: there is no final global settlement. Mesothelioma cases, by contrast, proceed separately in state courts, where juries awarded $32 million in Los Angeles and $10 million in New Orleans in 2026.
Who benefits:
- Women diagnosed with ovarian cancer after long-term use of the named talc products — Note your diagnosis date and use history, check your state’s deadline — there is no single national deadline, typically 1 to 3 years after diagnosis or discovery of the harm — and consult a licensed attorney in your state without delay.
- People diagnosed with mesothelioma after cosmetic talc exposure — Your case follows the state-court path, separate from MDL 2738: an attorney in your state can assess whether your exposure and diagnosis fit that path.
- People wondering whether the proposal covers them — Check the scope first: the proposal covers ovarian cancer only, roughly 76,000 claims, with a first payment of up to $3 billion targeted for 2027, and it excludes mesothelioma and future, unfiled claims.
Who does not benefit:
- People waiting for a final settlement that is already done — As of October 2026 there is none: the proposal is not a concluded agreement, and without 95% participation there is no deal at all.
- People who want a fixed payout figure — No reliable public per-case figures exist, because most settlements are confidential; compensation depends on your diagnosis, exposure history, jurisdiction, and the defendant’s conduct.
- People whose state deadline has already run out — Deadlines vary by state and generally run from diagnosis or discovery of the harm: waiting risks losing the right to file for good.
Related reading: Hair Relaxer Lawsuit Update October 2026.
Frequently asked questions
Is there a final talc settlement as of October 2026?
No. J&J's $5.5 billion proposal covers ovarian-cancer claims only, is conditional on 95% claimant participation, and is not a completed settlement.
What is the deadline to file a talc powder lawsuit?
There is no national deadline. Statutes of limitations vary by state, typically 1–3 years from diagnosis or discovery of the injury, so consult a licensed attorney in your state without delay.
How much does a talc lawyer cost?
Most firms work on contingency: nothing upfront, and 33–40% of the recovery if you win, plus case costs. You owe no fee if there is no recovery.
Do I qualify if I was diagnosed with mesothelioma, not ovarian cancer?
Mesothelioma claims tied to cosmetic talc exposure are a separate track, litigated individually in state courts. An attorney can assess whether your exposure history fits.
Does the $5.5 billion proposal cover future claims?
No. As announced, the proposal covers a defined set of roughly 76,000 pending ovarian-cancer claims and excludes mesothelioma claims and future, unfiled claims.
Who benefits from this talc lawsuit update — and who does not, and where do I start?
Women diagnosed with ovarian cancer after long-term use of the named talc products benefit, as do people diagnosed with mesothelioma after cosmetic talc exposure — whose cases proceed in state courts, separate from MDL 2738 — and people who want to check whether the proposal covers them: it covers ovarian cancer only, roughly 76,000 claims, conditional on 95% participation, with a first payment of up to $3 billion targeted for 2027. People waiting for a final settlement that is already done do not benefit — as of October 2026 there is none — nor do people who want a fixed figure, since no reliable public per-case figures exist, nor people whose state deadline has already run out. To start: note your diagnosis date and use history, check your state’s deadline, and consult a licensed attorney in your state without delay.
This article provides general information only and is not legal advice. Consult a licensed attorney in your state about your situation.